At Norton Cancer Institute, we are committed to giving our patients the opportunity to receive state-of-the-art, cutting-edge therapies. This is made possible because of the long-standing support of clinical trials by Norton Healthcare’s leadership and board of trustees. I specialize in blood cancers. Currently we have nearly 50 ongoing trials available to patients with multiple…
Ovarian cancer is personal to me. Two of my mom’s sisters died of the disease. One of the major issues with successfully treating ovarian cancer is how late it is typically diagnosed: stage IIIC. At that point, the cancer has spread throughout the abdominal cavity, and there are distant metastases throughout the omentum. Standard treatment…
Justin W. Gorski, M.D., Ph.D., has joined Norton Cancer Institute, specializing in treating cancers of the female reproductive system, including ovarian, uterine and cervical cancers. Dr. Gorski is a board-certified gynecologic oncologist. He received his medical training at the Drexel University College of Medicine in Philadelphia and completed his residency at the Icahn School of Medicine…
Our goal is to offer every patient the option of the latest treatment available for their cancer. To do that, Norton Cancer Institute is participating in approximately 170 clinical trials at any time. These clinical trials involve nearly 500 patients either enrolled and receiving treatment, or in follow-up. For the participating patients, these studies offer…
Cancer is a disease that impacts each individual differently. There is no one-size-fits-all approach to compassion and care. Just as we deliver individualized medicine, we deliver individualized care to ensure we meet the needs of the whole person. We know that cancer can be all-encompassing. Addressing the emotional health of patients is a vital part…
The patient A 25-year-old woman presented with recurrent left second metacarpal giant cell tumor of bone. She previously was treated with extensive curettage, bone graft substitute placement and Kirschner wire fixation. Giant cell tumor of bone is a benign aggressive tumor with a high rate of local recurrence and development of lung metastases in approximately…
Bereaved family members of adult oncology patients appear to have moderate acceptance and use of amplified cardiopulmonary recordings (ACPR) when created in the context of ongoing music therapy treatment, according to a recently published study. ACPR is a process-based music therapy intervention. Using a patient’s heartbeat to create a piece of music can be important…
Mia Jusufbegovic, M.D., has joined Norton Cancer Institute as its first head and neck oncology and microvascular reconstructive surgeon treating complex ear, nose and throat oncology cases. Dr. Jusufbegovic earned her medical degree from the University of Louisville School of Medicine, where she also completed her residency training in otolaryngology and head and neck surgery….
Douglas A. Nelson, M.D., has joined Norton Cancer Institute, practicing at the downtown Louisville and St. Matthews offices. Dr. Nelson most recently was an associate professor in the Department of Gastrointestinal Medical Oncology and Department of General Oncology at the University of Texas MD Anderson Cancer Center – The Woodlands, in Conroe. Dr. Nelson served as…
Clinical challenge Acute myeloid leukemia (AML) patients ages 75 and older, and younger adults with comorbidities, are often ineligible to receive standard intensive chemotherapy due to high rates of toxicity and early mortality. As a result, supportive care is all that’s available to about 60% of adults 75 or older and younger adults with comorbidities….
No one needs to face cancer alone. A cancer diagnosis is life-altering, and living with cancer can cause feelings of fear, sadness, nervousness and uncertainty, and a sense of being overwhelmed. At Norton Cancer Institute, the health care team understands that patients need both leading-edge medical care and support for their mental and emotional health…
Black Americans have the highest death rate and shortest survival rate of any racial or ethnic group in the U.S. for most cancers, according to a 2019 study. Lung cancer is the second most common cancer and the leading cause of cancer death in Black adults, according to the same study. The rate of new…